0000950123-24-008730.txt : 20240814
0000950123-24-008730.hdr.sgml : 20240814
20240814160003
ACCESSION NUMBER: 0000950123-24-008730
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240630
FILED AS OF DATE: 20240814
DATE AS OF CHANGE: 20240814
EFFECTIVENESS DATE: 20240814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Omega Fund Management, LLC
CENTRAL INDEX KEY: 0001637359
ORGANIZATION NAME:
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16844
FILM NUMBER: 241207127
BUSINESS ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
BUSINESS PHONE: 617 502 6538
MAIL ADDRESS:
STREET 1: 888 BOYLSTON ST., SUITE 1111
CITY: BOSTON
STATE: MA
ZIP: 02199
FORMER COMPANY:
FORMER CONFORMED NAME: Omega Fund Management (US) Inc.
DATE OF NAME CHANGE: 20150320
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
0001637359
XXXXXXXX
06-30-2024
06-30-2024
false
Omega Fund Management, LLC
888 BOYLSTON ST., SUITE 1111
BOSTON
MA
02199
13F HOLDINGS REPORT
028-16844
N
Alexia Pearsall
Chief Financial Officer, Omega Fund Management, LLC
617.921.2117
/s/ Alexia Pearsall
Boston
MA
08-14-2024
0
11
134971971
false
INFORMATION TABLE
2
34511.xml
INFORMATION TABLE FOR FORM 13F
Alumis Inc
Common Stock
022307102
8687893
653225
SH
SOLE
653225
0
0
enGene Holdings Inc.
Common Stock
29286M105
10150047
1076357
SH
SOLE
1076357
0
0
enGene Holdings Inc.
Warrant
29286M113
382587
321502
SH
SOLE
321502
0
0
Ikena Oncology
Common Stock
45175G108
3711053
2249123
SH
SOLE
2249123
0
0
Immunic Inc
Common Stock
4525EP101
1984858
1788160
SH
SOLE
1788160
0
0
Lexeo Therapeutics
Common Stock
52886X107
37788700
2355904
SH
SOLE
2355904
0
0
Morphic Holding
Common Stock
61775R105
5445953
159846
SH
SOLE
159846
0
0
Nuvation Bio
Common Stock Class A
67080N101
38765581
13275884
SH
SOLE
13275884
0
0
Replimune Group
Common Stock
76029N106
22151871
2461319
SH
SOLE
2461319
0
0
Sana Biotechnology, Inc.
Common Stock
799566104
4606875
843750
SH
SOLE
843750
0
0
Syros Pharmaceuticals
Common Stock
87184Q206
1296553
251270
SH
SOLE
251270
0
0